Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Enamelon (ENML) - Does anyone follow this? -- Ignore unavailable to you. Want to Upgrade?

To: Greg B. who wrote (477)	3/13/1998 5:01:00 PM
From: Harry Ehrlich	Read Replies (2) \| Respond to of 863

What's of interest here is that the news did not really move the stock today; all that volume and only a quarter point. In fact, this info has been available since March 4, when the meetings began. It seems that the stock sold off on this news initially. Today, there were many selling into this news rally. From the press release, it seems that none of the results were obtained from tests done on people, only on tissue. I could be wrong. The only test that seems to have been done on people was one that "showed electrical resistance measurements are a promising means of demonstrating the effectiveness of ENAMELON Toothpaste in human subjects." See if you can get the abstracts; we could use some clarification here. The market is usually right about these things. Harry